Axsome Therapeutics, Inc. (AXSM)
NASDAQ: AXSM · Real-Time Price · USD
165.51
-0.87 (-0.52%)
Mar 3, 2026, 1:35 PM EST - Market open
Axsome Therapeutics Market Cap
Axsome Therapeutics has a market cap or net worth of $8.47 billion as of March 3, 2026. Its market cap has increased by 32.67% in one year.
Market Cap
8.47B
Enterprise Value
8.41B
1-Year Change
32.67%
Ranking
Category
Stock Price
$165.51
Market Cap Chart
Since November 19, 2015, Axsome Therapeutics's market cap has increased from $154.90M to $8.47B, an increase of 5,365.71%. That is a compound annual growth rate of 47.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 2, 2026 | 8.51B | -7.56% |
| Dec 31, 2025 | 9.21B | 124.55% |
| Dec 31, 2024 | 4.10B | 8.87% |
| Dec 29, 2023 | 3.77B | 12.44% |
| Dec 30, 2022 | 3.35B | 135.22% |
| Dec 31, 2021 | 1.42B | -53.19% |
| Dec 31, 2020 | 3.04B | -14.70% |
| Dec 31, 2019 | 3.57B | 4,141.14% |
| Dec 31, 2018 | 84.10M | -36.58% |
| Dec 29, 2017 | 132.60M | 2.55% |
| Dec 30, 2016 | 129.30M | -21.30% |
| Dec 31, 2015 | 164.30M | 6.07% |
| Nov 19, 2015 | 154.90M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Madrigal Pharmaceuticals | 9.99B |
| Praxis Precision Medicines | 9.21B |
| ABIVAX Société Anonyme | 9.05B |
| Bio-Techne | 9.05B |
| Arrowhead Pharmaceuticals | 9.01B |
| Vaxcyte | 8.92B |
| Halozyme Therapeutics | 8.24B |
| Nuvalent | 7.96B |